Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.62 - $1.0 $33 - $54
54 New
54 $0
Q4 2022

Feb 10, 2023

SELL
$0.54 - $9.8 $233 - $4,233
-432 Reduced 91.91%
38 $0
Q3 2022

Nov 14, 2022

SELL
$0.13 - $12.4 $39 - $3,794
-306 Reduced 39.43%
470 $0
Q2 2022

Aug 12, 2022

SELL
$1.11 - $3.46 $2,223 - $6,930
-2,003 Reduced 72.08%
776 $1,000
Q1 2022

May 16, 2022

BUY
$1.78 - $8.5 $1,076 - $5,142
605 Added 27.83%
2,779 $10,000
Q4 2021

Feb 08, 2022

BUY
$7.3 - $11.24 $15,870 - $24,435
2,174 New
2,174 $16,000

Others Institutions Holding SABS

About SAB Biotherapeutics, Inc.


  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $184M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.